Annual Drug Patent Expirations for VARUBI
Varubi is a drug marketed by Tersera and is included in two NDAs. It is available from two suppliers. There are nine patents protecting this drug.
This drug has one hundred and fifty-four patent family members in thirty-five countries.
The generic ingredient in VARUBI is rolapitant hydrochloride. Two suppliers are listed for this compound. Additional details are available on the rolapitant hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
